VolitionRx Statistics

Total Valuation

VolitionRx has a market cap or net worth of $57.07 million. The enterprise value is $64.22 million.

Market Cap	57.07M
Enterprise Value	64.22M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

VolitionRx has 103.02 million shares outstanding. The number of shares has increased by 17.60% in one year.

Current Share Class	103.02M
Shares Outstanding	103.02M
Shares Change (YoY)	+17.60%
Shares Change (QoQ)	+3.11%
Owned by Insiders (%)	7.71%
Owned by Institutions (%)	12.80%
Float	71.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.77
Forward PS	11.68
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	49.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.34
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-67.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-108.04%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-9,783.93%
Revenue Per Employee	$15,392
Profits Per Employee	-$282,638
Employee Count	85
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.53% in the last 52 weeks. The beta is 1.06, so VolitionRx's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-18.53%
50-Day Moving Average	0.50
200-Day Moving Average	0.61
Relative Strength Index (RSI)	59.43
Average Volume (20 Days)	291,316

Short Selling Information

The latest short interest is 346,718, so 0.34% of the outstanding shares have been sold short.

Short Interest	346,718
Short Previous Month	495,400
Short % of Shares Out	0.34%
Short % of Float	0.48%
Short Ratio (days to cover)	1.81

Income Statement

In the last 12 months, VolitionRx had revenue of $1.31 million and -$24.02 million in losses. Loss per share was -$0.27.

Revenue	1.31M
Gross Profit	1.31M
Operating Income	-24.16M
Pretax Income	-34.91M
Net Income	-24.02M
EBITDA	-23.06M
EBIT	-24.16M
Loss Per Share	-$0.27

Full Income Statement

Balance Sheet

The company has $2.60 million in cash and $7.37 million in debt, giving a net cash position of -$4.77 million or -$0.05 per share.

Cash & Cash Equivalents	2.60M
Total Debt	7.37M
Net Cash	-4.77M
Net Cash Per Share	-$0.05
Equity (Book Value)	-29.03M
Book Value Per Share	-0.28
Working Capital	-4.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.85 million and capital expenditures -$250,498, giving a free cash flow of -$22.10 million.

Operating Cash Flow	-21.85M
Capital Expenditures	-250,498
Free Cash Flow	-22.10M
FCF Per Share	-$0.21

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,846.75%
Pretax Margin	-1,854.43%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VolitionRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.60%
Shareholder Yield	-17.60%
Earnings Yield	-40.41%
FCF Yield	-37.17%

Analyst Forecast

The average price target for VolitionRx is $4.17, which is 652.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.17
Price Target Difference	652.71%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	176.02%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VolitionRx has an Altman Z-Score of -47.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-47.58
Piotroski F-Score	2